CAT# | F03001 |
Sequence | ADSGEGDFLAEGGGVR |
Length | 16 | Modifications | Phosphoserine |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
F03002 | Fibrinopeptide B | Inquiry | ||
F03004 | (Tyr0)-Fibrinopeptide A (human) | Inquiry | ||
F03005 | (Tyr15)-Fibrinopeptide B (human) | Inquiry | ||
F03003 | (Glu1)-Fibrinopeptide B (human) | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. Emu oil in combination with other active ingredients for treating skin imperfections
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
of Tripeptide-1 The tripeptide-1 (glycyl-L-histadyl-L-lysine or GHK) is primarily known as carrier peptides. It ...
KAI-1678, a synthetic 21-amino acid, is a novel PKC-epsilon (ε-PKC) inhibitor with a molecular weight of 2541 Da ...
Factors of natural aging Natural aging of the skin results in decreased production and increased degradation of extracellula ...
Topotecan (TPT) is a water-soluble, semi-synthetic camptothecin derivative developed by Smithkline Beecham, USA. ...
Orexin A (OXA) and orexin B (OXB) are hypothalamic neuropeptides discovered in 1998, which bind to two G-protein ...